Commentary on “Electroacupuncture Inhibited Spinal Glial Activation in Neuropathic Pain via Glucagon-like Peptide 1/Glucagon-like Peptide 1 Receptor Signaling”
Author:
Open Access
- 1 July 2024
- journal article
- editorial
- Published by Medknow in Neurological Sciences and Neurophysiology
- Vol. 41 (3) , 190-191
Abstract
Neuropathic pain represents a significant clinical challenge due to its complex etiology and limited treatment options. Traditional pharmacological approaches, particularly opioid therapy, are associated with significant side effects and risk of abuse, highlighting the urgent need for alternative strategies. In recent years, nonpharmacological interventions such as acupuncture and electroacupuncture have gained attention for their potential efficacy in managing neuropathic pain. Further research combining nonpharmacological interventions with targeting signaling pathways could lead to the development of innovative strategies for the management of neuropathic pain and improve the quality of life for patients suffering from this debilitating condition.Keywords
This publication has 7 references indexed in Scilit:
- Activation of locus coeruleus-spinal cord noradrenergic neurons alleviates neuropathic pain in mice via reducing neuroinflammation from astrocytes and microglia in spinal dorsal hornJournal of Neuroinflammation, 2022
- Neuropathic Pain: From Mechanisms to TreatmentPhysiological Reviews, 2021
- Glucagon-like peptide 1 in health and diseaseNature Reviews Endocrinology, 2018
- Inflammation in the pathophysiology of neuropathic painPain, 2017
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisThe Lancet Neurology, 2015
- Activation of Spinal Glucagon-Like Peptide-1 Receptors Specifically Suppresses Pain HypersensitivityThe Journal of Neuroscience, 2014
- Mechanisms of Acupuncture–Electroacupuncture on Persistent PainAnesthesiology, 2014